Arvinas (ARVN) EBIT Margin (2017 - 2026)

Arvinas' (ARVN) quarterly EBIT Margin came in at 408.97% in Q1 2026, down 44679.0% year-on-year from N/an in Q1 2025, and up 47.92% quarter-over-quarter from 785.26% in Q4 2025.

Arvinas (ARVN) EBIT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBIT Margin history runs 10 years deep, the most recent figure standing at 408.97% for Q1 2026.

  • On a quarterly basis, EBIT Margin fell 44679.0% year-over-year to 408.97% in Q1 2026; TTM through Mar 2026 was 283.78%, a 26139.0% decrease from a year earlier, with the FY2025 full-year figure at 45.13%, up 4986.0% from the prior year.
  • EBIT Margin rose to 408.97% in Q1 2026 per ARVN's latest filing, from 785.26% in the prior quarter.
  • Across five years, EBIT Margin topped out at 383.53% in Q4 2023 and bottomed at 785.26% in Q4 2025.
  • The 5-year median for EBIT Margin is 194.67% (2022), against an average of 186.64%.
  • Across the five-year window, EBIT Margin soared 74896 bps in 2022 and sank 68695 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 200.0% in 2022, then jumped by 292 bps to 383.53% in 2023, then plunged by 126 bps to 98.31% in 2024, then tumbled by 699 bps to 785.26% in 2025, then soared by 48 bps to 408.97% in 2026.
  • Per Business Quant, the three latest ARVN EBIT Margin figures stand at 408.97% (Q1 2026), 785.26% (Q4 2025), and 104.53% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arvinas 519.68 Mn -95.22 Mn - -408.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 -408.97%
Dec 31, 2025 -785.26%
Sep 30, 2025 -104.53%
Jun 30, 2025 -319.20%
Mar 31, 2025 37.82%
Dec 31, 2024 -98.31%
Sep 30, 2024 -58.89%
Jun 30, 2024 -63.40%
Mar 31, 2024 -329.25%
Dec 31, 2023 383.53%
Sep 30, 2023 -213.58%
Jun 30, 2023 -136.88%
Mar 31, 2023 -269.85%
Dec 31, 2022 -200.00%
Sep 30, 2022 -193.67%
Jun 30, 2022 -194.67%
Mar 31, 2022 -217.74%
Dec 31, 2021 -143.07%
Sep 30, 2021 -508.60%
Jun 30, 2021 -943.64%